Kudan, Prodelight, etc.
<206A> Prism BioLab, Kichiro Nakajima's shareholding percentage -% -> 5.29%, reporting obligation date July 2, 2024. <206A> Prism BioLab, Daichi Takehara's shareholding percentage -% -> 6.17%, reporting obligation date July 2, 2024. <206A> Prism BioLab, Eli Lilly and Company shares.
Komeda, Maruzen, Shikaku, Yoshinoya HD (10 days)
※The above calendar is subject to change due to company scheduling. --------------------------------------- July 10th (Wednesday) <1376> Kaneko Seeds <2157> Koshidaka HD <2338> QuantumS <2653> Aeon Kyushu <2686> Geefoot <2687> CVS Bay <2735> Watts <2747> Kitao Lucky
Dip, Keishin, Nakakita Seisakusho, TAKARA & COMPANY (9th)
※The above calendar is just a plan and may be subject to change due to corporate reasons.---------------------------------------July 9th (Tue) <2379> Dip <2668> Tabio <2792> Honeys HD <2882> Eat and <2918> Warabe Nichiyoh <3222> USMH <3454> F Brothers <4173> WACUL <4735>
KG Information, Welcia HD, WNI weather, UNEXT (8th)
※The above calendar is only a plan and may be subject to changes due to the company's convenience. --------------------------------------- July 8th (Monday) <2408> KG Information <3141> Welcia HD <3148> Create SD <3236> Propast <3280> Estrasti <3353> Medi-ikko G <4825> WNI Weather <7811> Nakamoto Pack
Start offering the AI utilization reskilling seminar for companies, "Generating AI Work Efficiency Course" by TWOST.
TWOSTONE&Sons <7352> announced on the 28th that its fully-owned subsidiary, Branding Career, has launched a training course for corporate AI utilization called 'Generating AI Business Efficiency Course'. This training course is eligible for the talent development support grant system set by the Ministry of Health, Labour and Welfare, allowing participating companies to receive up to 75% subsidy of the tuition fee and achieve overall business efficiency within the company while keeping costs low. In order for participating companies to receive the grant, certain requirements must be met.
TWOSTONE & Sons has renewed the logo for the "TechStars Agent" program.
TWOSTONE & Sons <7352> announced on the 25th that its subsidiary Branding Career has renewed its logo at "TechStars Agent" and launched "Stars Agent" at the same time. TechStars Agent is a job change support service specializing in IT engineers. The company has specialized in supporting job changes for IT engineers and, in the recent term, it carried out the support specialized for IT engineers, with the total sum of 8.8 billion yen (as of August 2023).
Merger between TSr and TSR Solutions, subsidiaries of TWOST, has been completed.
TWOSTONE&Sons <7352> announced on the 3rd that it has completed the absorption merger of its consolidated subsidiary TSR, with TSR Solutions, another consolidated subsidiary of the same company, being dissolved and TSR being the surviving company, taking effect on June 1. With this merger, the strengths of TSR's infrastructure area and TSR Solutions' development area will be combined, making it possible to provide one-stop services from infrastructure to development and maintenance operations for customer companies.
Two stone & Sons: Revised Extraordinary Report
The Tokyo Stock Exchange Growth Index rebounded, and the increase steadily widened until the previous closing
TSE Growth Market Index 824.17 +13.22/ Volume 125.6 million shares/ trading price 121.7 billion yen TSE Growth Market 250 Index 642.45 +9.47/ turnover 96.77 million shares/ trading price 108.3 billion yen Today's growth market rebelled against both the TSE Growth Market Index and the TSE Growth Market 250 Index. The number of rising stocks is 357, the number of falling stocks is 182, and 35 unchanged. The Dow average rose by $134.21 to 40003.59 in the US market on the 17th
Two stone & Sons: Extraordinary Report
Two stone & Sons: Announcement of the release of financial results explanation video and transcript for the fiscal year ending 2024/8
Medrex, Blue Innovations, etc.
<153A>Kaulis Co., Ltd. Shimazu Atsuyoshi Stock Ownership Ratio 59.63% → 55.71% Reporting Obligation Date 2024/04/25 <3133>Kaiho Co., Ltd. Yamada Toru Stock Ownership Ratio 12.99% → 14.18% Reporting Obligation Date 2024/04/26 <3976>Shannon Co., Ltd. Wiz Partners Co., Ltd. Stock Ownership Ratio 57.31% → 58.54% Reporting Obligation Date 2024/05/0
TwoStone&Sons --- subsidiary Branding Career forms a business partnership with Parasol
TwoStone&Sons <7352> announced on the 2nd that its subsidiary Brand Career has concluded a business alliance with Parasol (headquarters: Minato-ku, Tokyo). Parasol operates the personalized marriage hunting service “Human Oshi.” We will work on making service proposals from both companies and holding co-hosted events and consultations for users who use the services of both companies. Branding Career said, “By successfully changing jobs, you can be positive about marriage
Volume change rate ranking (13:00) ~ Amatei, Mitsui Matsushima, etc. are ranked
* In the volume change rate ranking, it is possible to know the interest of market participants, such as shopping trends, by comparing the average turnover for the last 5 days with the turnover on the day of distribution. ■Top Volume Change Rate [5/2 13:32 as of] (Last 5 Day Average Volume Comparison) Code ⇒ Stock ⇒ Volume ⇒ 5 Day Average Volume ⇒ Volume Change Ratio ⇒ Stock Price Change Ratio <9331> Caster 662100 18601.1 365.35% 0.1073% <7172> JIA
TwoStone&SONS---Expert Partners Marketing has surpassed 5,000 registrants
TwoStone&Sons <7352> announced on the 1st that the number of registrants has exceeded 5,000 at “Expert Partners Marketing” operated by the subsidiary Digital Arrow Partners. Expert Partners Marketing is a service where professional marketers solve corporate marketing issues. We propose excellent marketing human resources at spots and fixed prices to companies, and marketers
Brands that moved the day before part 2 Nex Group, Nippon Food Chemical, Tokyo Electron Devices, etc.
<コード>Stock name 1 day closing price ⇒ compared to the previous day Tokyo Electron Device <2760> 5180 -560 The outlook for profit declines and dividends for the current fiscal year is viewed negatively. DMmix <7354> 243 -17 Recently, the ownership ratio of newton implants has declined. Chugoku Electric Power <9504> 1000.0 -85.5 I'm disgusted by the drastic decline in consensus guidance for the current fiscal year. Enplus <6961> 8300 -410 consensus is declining while forecasting a drastic increase in profit this fiscal year. Otsuka
Core concept technology, 3-D matrix, etc.
<157A>Green Monster Co., Ltd. Ogawa Ryo Stock Ownership Ratio -% → 34.80% Reporting Obligation Date 2024/04/26 <176A>Regil Corporation Kansai Electric Power Co., Ltd. Stock Ownership Ratio -% → 9.92% Reporting Obligation Date 2024/04/24 <3133>Kaiho Co., Ltd. Yamada Toru Stock Holding Ratio 12.99% → 14.18% Reporting Obligation Date 2024/04/26 <4169>ENECH
TWOST--- Resolved to issue new shares through overseas offerings
TwoStone&Sons <7352> announced on the 12th that it will issue new shares through overseas offerings. Macquarie Capital Limited (underwriter) will purchase and undertake the purchase of 1,230,000 shares of the company's common stock, and will conduct recruitment in overseas markets (excluding the United States and Canada) centered on Europe and Asia. The issue price is a book building method similar to the method stipulated in section 25 of the Regulations on Underwriting of Marketable Securities stipulated by the Japan Securities Dealers Association
TWOST---2Q also increased sales by 2 digits, accelerated strategic investment in anticipation of medium- to long-term expansion, and issuance of new shares through overseas offerings
TwoStone&Sons <7352> announced consolidated financial results for the 2nd quarter (23/9/24 to 2/24) of the fiscal year ending 2024/8 on the 12th. Net sales increased 41.5% from the same period last year to 6.49 billion yen, operating profit decreased 52.2% to 67 million yen, ordinary profit decreased 53.0% to 65 million yen, and quarterly net profit attributable to parent company shareholders decreased 86.2% to 0.13 billion yen. Sales hit a record high for 14 consecutive quarters. In the IT market which is highly correlated with the company's business domain
Astellas Pharmaceuticals, 24/3 revised downward operating profit 13 billion yen ← 83 billion yen
Astellas Pharmaceuticals <4503> announced revisions to its earnings forecast for the fiscal year ending 2024/3. Operating profit was revised downward from 83 billion yen to 13 billion yen. As a result of reviewing the asset value of the gene therapy program AT808, which is undergoing research and development for Friedreich ataxia patients, impairment losses of approximately 40 billion yen of intangible assets related to AT808 will be recorded as other expenses. [Positive Evaluation] <8233>Takashimaya Full Year | <6432>Takeuchi Production
No Data